×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PBH – prestige consumer healthcare inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PBH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/10
08:11 pm
pbh
PBH vs. SYK: Which Stock Is the Better Value Option? [Yahoo! Finance]
Low
Report
PBH vs. SYK: Which Stock Is the Better Value Option? [Yahoo! Finance]
4/10
05:00 pm
pbh
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
Low
Report
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
4/8
11:31 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/8
11:29 am
pbh
Smile in Strides: Goody's® Pain Relief Encourages Runners to Harness the Power of a Simple Smile to Reduce Pain and Boost Performance [Yahoo! Finance]
Low
Report
Smile in Strides: Goody's® Pain Relief Encourages Runners to Harness the Power of a Simple Smile to Reduce Pain and Boost Performance [Yahoo! Finance]
3/21
12:39 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target raised by analysts at Royal Bank of Canada from $96.00 to $97.00. They now have a "sector perform" rating on the stock.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target raised by analysts at Royal Bank of Canada from $96.00 to $97.00. They now have a "sector perform" rating on the stock.
3/18
02:06 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/10
11:02 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/7
02:39 am
pbh
Feminine Intimate Care Market to Reach $14 billion, Globally, by 2034 at 6.1% CAGR: Allied Market Research [Yahoo! Finance]
Low
Report
Feminine Intimate Care Market to Reach $14 billion, Globally, by 2034 at 6.1% CAGR: Allied Market Research [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/6/2025
06:00 am
PBH
prestige consumer healthcare inc.
BEAT
Report
10.6%
prestige consumer healthcare inc.
2/6/2025
06:00 am
PBH
prestige consumer healthcare inc.
BEAT
Report
10.6%
prestige consumer healthcare inc.
2/6/2025
06:00 am
PBH
prestige consumer healthcare inc.
BEAT
Report
10.6%
prestige consumer healthcare inc.
2/6/2025
06:00 am
PBH
prestige consumer healthcare inc.
BEAT
Report
13.7%
prestige consumer healthcare inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/12
04:01 pm
pbh
Form 4 Prestige Consumer Health For: Mar 10 Filed by: Fritz Mary Beth
Low
Report
Form 4 Prestige Consumer Health For: Mar 10 Filed by: Fritz Mary Beth
3/10
01:06 pm
pbh
Form 144 Prestige Consumer Health Filed by: Fritz Mary Beth
Low
Report
Form 144 Prestige Consumer Health Filed by: Fritz Mary Beth
3/5
04:01 pm
pbh
Form 4 Prestige Consumer Health For: Mar 03 Filed by: Fritz Mary Beth
Low
Report
Form 4 Prestige Consumer Health For: Mar 03 Filed by: Fritz Mary Beth
3/3
04:12 pm
pbh
Form 144 Prestige Consumer Health Filed by: Fritz Mary Beth
Low
Report
Form 144 Prestige Consumer Health Filed by: Fritz Mary Beth
2/13
04:01 pm
pbh
Form 4 Prestige Consumer Health For: Feb 11 Filed by: Mekhail Adel
Low
Report
Form 4 Prestige Consumer Health For: Feb 11 Filed by: Mekhail Adel
2/11
04:09 pm
pbh
Form 144 Prestige Consumer Health Filed by: Mekhail Adel
Low
Report
Form 144 Prestige Consumer Health Filed by: Mekhail Adel
2/7
07:43 am
pbh
Form SCHEDULE 13G/A Prestige Consumer Health Filed by: MACQUARIE GROUP LTD
Low
Report
Form SCHEDULE 13G/A Prestige Consumer Health Filed by: MACQUARIE GROUP LTD
2/6
06:09 am
pbh
Form 10-Q Prestige Consumer Health For: Dec 31
High
Report
Form 10-Q Prestige Consumer Health For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/26
Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating.
14.3%
3/23 Prestige Consumer Healthcare Inc (NYSE: PBH) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "market perform" rating on the stock. 9.7%
2/6 Q3/2020 12/31/2019 EPS 0.810 ZacksConsensus 0.750 ActVsEst 0.060 - Beat 8.4%
11/1 Prestige Consumer Healthcare's (PBH) CEO Ron Lombardi on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha] 6.1%
3/2 Form 8-K Prestige Consumer Health For: Mar 02 4.9%
3/18 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 4.4%
11/1 Prestige Consumer Healthcare Inc (PBH) Q2 2020 Earnings Call Transcript [The Motley Fool] 4.1%
4/27 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results 3.1%
5/9 Q4/2019 3/31/2019 EPS 0.720 ZacksConsensus 0.700 ActVsEst 0.020 - Beat 2.7%
12/16 Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. 2.5%
3/23 Prestige Consumer Healthcare Inc (NYSE: PBH) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "market perform" rating on the stock. 9.7%
2/6 Q3/2020 12/31/2019 EPS 0.810 ZacksConsensus 0.750 ActVsEst 0.060 - Beat 8.4%
11/1 Prestige Consumer Healthcare's (PBH) CEO Ron Lombardi on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha] 6.1%
3/2 Form 8-K Prestige Consumer Health For: Mar 02 4.9%
3/18 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 4.4%
11/1 Prestige Consumer Healthcare Inc (PBH) Q2 2020 Earnings Call Transcript [The Motley Fool] 4.1%
4/27 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results 3.1%
5/9 Q4/2019 3/31/2019 EPS 0.720 ZacksConsensus 0.700 ActVsEst 0.020 - Beat 2.7%
12/16 Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. 2.5%
TOP News Decliners
4/14
Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating.
-4.9%
2/8 Prestige Consumer Healthcare Inc (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. -4.6%
5/12 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.0%
9/13 Form 4 Prestige Consumer Health For: Sep 12 Filed by: Sacco Christine -2.9%
8/1 Prestige Consumer Healthcare Inc. Reports Fiscal 2020 First Quarter Results -2.8%
8/3 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -2.8%
1/6 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Third Quarter Earnings Results -2.7%
11/15 Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes -2.5%
12/31 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock. -1.7%
4/15 Prestige Consumer Healthcare Inc (NYSE: PBH) had its price target raised by analysts at DA Davidson from $43.00 to $47.00. -1.6%
2/8 Prestige Consumer Healthcare Inc (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. -4.6%
5/12 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.0%
9/13 Form 4 Prestige Consumer Health For: Sep 12 Filed by: Sacco Christine -2.9%
8/1 Prestige Consumer Healthcare Inc. Reports Fiscal 2020 First Quarter Results -2.8%
8/3 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -2.8%
1/6 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Third Quarter Earnings Results -2.7%
11/15 Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes -2.5%
12/31 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock. -1.7%
4/15 Prestige Consumer Healthcare Inc (NYSE: PBH) had its price target raised by analysts at DA Davidson from $43.00 to $47.00. -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: